Activation of the κ-opioid receptor in Caco-2 cells decreases interleukin-8 secretion

European Journal of Pharmacology

Volumn 467, Issue 1-3, 2003, Pages 81-84

  Neudeck, Brien L ^a   Loeb, Jennifer ^a   Buck, Jessica ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Caco 2 cell; Interleukin 8; Opioid receptor; Opioid receptor agonist

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BINALTORPHIMINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST;

ARTICLE; CELL STRAIN CACO 2; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; EPITHELIUM; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 0037466411     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01633-9     Document Type: Article

References (10)

1. Alicea C., Belkowski S., Eisenstein T.K., Adler M.W., Rogers T.J. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50, 488H. J. Neuroimmunol. 64:1996;83-90.
2. Belkowski S.M., Alicea C., Eisenstein T.K., Adler M.W., Rogers T.J. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H. J. Pharmacol. Exp. Ther. 273:1995;1491-1496.
3. Bush K.A., Kirkham B.W., Walker J.S. The kappa-opioid agonist, asimadoline, alters cytokine gene expression in adjuvant arthritis. Rheumatology. 40:2001;1013-1021.
4. Butelman E.R., Ko M.C., Traynor J.R., Vivian J.A., Kreek M.J., Woods J.H. GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. J. Pharmacol. Exp. Ther. 298:2001;1049-1059.
5. Jijon H.B., Panenka W.J., Madsen K.L., Parsons H.G. MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. Am. J. Physiol., Cell Physiol. 283:2002;C31-C41.
6. Morgan E.L. Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists. J. Neuroimmunol. 65:1996;21-30.
7. Neudeck B.L., Loeb J.M. Endomorphin-1 alters interleukin-8 secretion in Caco-2 cells via a receptor mediated process. Immunol. Lett. 84:2002;217-221.
8. Thorpe C.M., Smith W.E., Hurley B.P., Acheson D.W. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect. Immun. 69:2001;6140-6147.
9. Xie G.X., Meuser T., Pietruck C., Sharma M., Palmer P.P. Presence of opioid receptor-like (ORL1) receptor mRNA splice variants in peripheral sensory and sympathetic neuronal ganglia. Life Sci. 64:1999;2029-2037.
10. Zhang L., Rogers T.J. Kappa-opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression. J. Immunol. 164:2000;5088-5093.